The Histone Methyltransferase KMT2D is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration Resistant Prostate Cancer [LNCaP Bulk RNA-Seq]
Single-cell RNA-seq · human · 16 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Homo sapiens (human)
- Samples
- 16 samples: 8 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate CancerCancer research · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE296115_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1257816 and SRA study SRP582595. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 16 samples.
How we read this: 8 replicated groups read from 16 sample titles; they account for 16 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8965425 LNCAP_control_DHT_rep1 LNCAP_control_DHT
- GSM8965426 LNCAP_control_DHT_rep2 LNCAP_control_DHT
- GSM8965427 LNCAP_control_DHT+GDC0941_rep1 LNCAP_control_DHT+GDC09…
- GSM8965428 LNCAP_control_DHT+GDC0941_rep2 LNCAP_control_DHT+GDC09…
- GSM8965429 LNCAP_control_DMSO_rep1 LNCAP_control_DMSO
- GSM8965430 LNCAP_control_DMSO_rep2 LNCAP_control_DMSO
- GSM8965431 LNCAP_control_GDC0941_rep1 LNCAP_control_GDC0941
- GSM8965432 LNCAP_control_GDC0941_rep2 LNCAP_control_GDC0941
- GSM8965433 LNCAP_shKMT2D_DHT_rep1 LNCAP_shKMT2D_DHT
- GSM8965434 LNCAP_shKMT2D_DHT_rep2 LNCAP_shKMT2D_DHT
- GSM8965435 LNCAP_shKMT2D_DHT+GDC0941_rep1 LNCAP_shKMT2D_DHT+GDC09…
- GSM8965436 LNCAP_shKMT2D_DHT+GDC0941_rep2 LNCAP_shKMT2D_DHT+GDC09…
- GSM8965437 LNCAP_shKMT2D_DMSO_rep1 LNCAP_shKMT2D_DMSO
- GSM8965438 LNCAP_shKMT2D_DMSO_rep2 LNCAP_shKMT2D_DMSO
- GSM8965439 LNCAP_shKMT2D_GDC0941_rep1 LNCAP_shKMT2D_GDC0941
- GSM8965440 LNCAP_shKMT2D_GDC0941_rep2 LNCAP_shKMT2D_GDC0941
- GSE253957 Methylation of the epigenetic regulator KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer [SMYD2_KD_RNA] 12 samples shares kmt2d, therapeutic
- GSE293567 The H3K4 methyltransferase KMT2D is an essential cofactor for GATA1 at erythroid gene enhancers 67 samples shares kmt2d, methyltransferase
- GSE280973 Transcriptional Regulation of Protein Synthesis by Mediator Kinase Represents a Therapeutic Vulnerability in MYC-driven Medulloblastoma 20 samples shares therapeutic, mediator
- GSE302350 KMT2D-deficiency destabilizes lineage progression in immature neural progenitors 16 samples shares kmt2d
- GSE309595 Longitudinal Analysis of Multiple Myeloma: Therapeutic Response and Immune Microenvironment Dynamics in the Context of Tumor Heterogeneity [scRNA-seq] 270 samples shares therapeutic
- GSE215274 Identification of Whole Blood Gene Expression Signature to Predict the Therapeutic Effect of Nintedanib in Idiopathic Pulmonary Fibrosis 177 samples shares therapeutic
- GSE275870 Expression profiling of primary and metastatic oral squamous cell carcinoma identifies progression-associated transcriptome changes and therapeutic vulnerabilities 108 samples shares therapeutic
- GSE294016 A macrophage-predominant, immunosuppressive immune microenvironment and subtype-specific therapeutic vulnerabilities in advanced salivary gland cancer [bulk RNA-seq] 95 samples shares therapeutic
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.